Sanofi-Synthelabo
New York Division
90 Park Avenue
New York City
New York
10016-1301
U.S.A.
Phone:
212-551-4000
Fax:
|
Sanofi-Synthelabo is a global healthcare company. With annual sales in excess of $5.5 billion and 30,000 employees in more than 100 countries, Sanofi-Synthelabo ranks among the world's top 20 pharmaceutical companies and the top seven pharmaceutical companies in Europe. World headquarters are in Paris, France. U.S. headquarters are in New York City.
In the U.S., as in other major markets, the principle area of business of Sanofi-Synthelabo is ethical pharmaceuticals. Core therapeutic areas are cardiovascular disease and thrombosis, diseases of the central nervous system, cancer, and internal medicine.
The foundation of Sanofi-Synthelabo's worldwide growth is a highly regarded Research and Development program, with about 50 compounds under development, half of which are in Phase II and Phase III. Sanofi-Synthelabo has more than 6,000 scientists and R&D support staff in Europe and the U.S.
As we continue intensifying our selling efforts in the U.S., we're planning to add 1,000 more Sales Professionals to a Sales Force that has already doubled in size in just the last two years. In addition, we have a number of Division Manager career opportunities available in select markets throughout the country.
Join us in our fight for health. Healthy sales are sure to follow.
Last Updated 8-29-01
Email:
Ownership:
Web Site:
Sanofi-Synthelabo
Employees:
Symbol: SNY
|